vTv Therapeutics Inc (VTVT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $78.99M
Last updated: Nov 17, 2026 at 11:05 AM ET
vTv Therapeutics Inc (VTVT) Earnings: Report Dates and Results
vTv Therapeutics (VTVT) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, vTv Therapeutics reported EPS of -$0.94, above the -$1.07 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
VTVT has an expected report date of Mar 8, 2027.
Earnings History
Of the 37 quarters below that had an estimate, VTVT beat 20, missed 14 and matched 3. The widest gap in the table came in the quarter ended Mar 31, 2026, when EPS landed 685.71% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.94 | -$1.07 | -$1.29 - -$0.67 | +12.15% | Beat | N/A | 6 | 1 up, 1 down | Nov 5, 2026 | N/A |
| Jun 30, 2026 | -$1.05 | -$0.75 | -$1.27 - -$0.61 | -40.00% | Miss | N/A | 5 | 0 up, 1 down | Aug 6, 2026 | N/A |
| Mar 31, 2026 | $1.65 | $0.21 | -$0.95 - $0.99 | +685.71% | Beat | N/A | 6 | 4 up, 0 down | May 13, 2026 | $36.84M |
| Dec 31, 2025 | -$0.58 | -$1.09 | -$1.49 - -$0.66 | +46.69% | Beat | N/A | 5 | 0 up, 1 down | Mar 10, 2026 | N/A |
| Sep 30, 2025 | -$1.08 | -$0.98 | -$0.99 - -$0.97 | -10.20% | Miss | N/A | 2 | 0 up, 2 down | Nov 6, 2025 | N/A |
| Jun 30, 2025 | -$0.92 | -$0.82 | -$0.85 - -$0.80 | -12.20% | Miss | N/A | 2 | 2 up, 0 down | Aug 12, 2025 | N/A |
| Mar 31, 2025 | -$0.77 | -$0.73 | -$0.90 - -$0.73 | -5.48% | Miss | N/A | 2 | 1 up, 0 down | May 15, 2025 | N/A |
| Dec 31, 2024 | -$0.55 | -$0.87 | N/A | +36.55% | Beat | N/A | N/A | N/A | Mar 20, 2025 | $17000 |
| Sep 30, 2024 | -$0.88 | -$3.60 | N/A | +75.56% | Beat | N/A | N/A | N/A | Nov 12, 2024 | N/A |
| Jun 30, 2024 | -$0.81 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 8, 2024 | N/A |
| Mar 31, 2024 | -$1.17 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 9, 2024 | $1.00M |
| Dec 31, 2023 | -$1.67 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | Mar 13, 2024 | N/A |
| Sep 30, 2023 | -$3.20 | -$3.20 | N/A | 0.00% | Miss | N/A | N/A | 0 up, 0 down | Nov 9, 2023 | N/A |
| Jun 30, 2023 | -$0.07 | -$0.07 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Aug 11, 2023 | N/A |
| Mar 31, 2023 | -$0.06 | -$0.09 | -$0.11 - -$0.08 | +33.33% | Beat | N/A | 2 | 0 up, 0 down | May 11, 2023 | N/A |
| Dec 31, 2022 | -$2.40 | -$2.40 | -$2.80 - -$2.00 | 0.00% | In line | N/A | 3 | 0 up, 0 down | Mar 6, 2023 | $9000 |
| Sep 30, 2022 | -$2.00 | -$1.80 | -$2.40 - -$1.20 | -11.11% | Miss | N/A | 3 | 0 up, 0 down | Nov 10, 2022 | N/A |
| Jun 30, 2022 | -$1.60 | -$4.00 | N/A | +60.00% | Beat | N/A | N/A | 0 up, 0 down | Aug 15, 2022 | $9000 |
| Mar 31, 2022 | -$4.00 | -$3.20 | -$3.20 - -$3.20 | -25.00% | Miss | N/A | 1 | 0 up, 0 down | May 12, 2022 | $2.00M |
| Dec 31, 2021 | -$0.11 | -$0.07 | -$0.10 - -$0.05 | -57.14% | Miss | -650.0% | 2 | 0 up, 0 down | Mar 29, 2022 | $9000 |
| Sep 30, 2021 | -$0.80 | -$2.80 | -$3.60 - -$2.00 | +71.43% | Beat | N/A | 2 | 0 up, 0 down | Nov 9, 2021 | $3.00M |
| Jun 30, 2021 | -$0.40 | -$2.80 | -$3.60 - -$2.00 | +85.71% | Beat | N/A | 2 | N/A | Aug 4, 2021 | $9000 |
| Mar 31, 2021 | -$3.20 | -$2.40 | -$3.60 - -$1.20 | -33.33% | Miss | N/A | 2 | N/A | May 5, 2021 | $987000 |
| Dec 31, 2020 | $0.02 | -$0.05 | -$0.10 - -$0.01 | +140.00% | Beat | N/A | 2 | N/A | Feb 24, 2021 | $6.40M |
| Sep 30, 2020 | -$1.20 | -$4.20 | -$6.40 - -$1.20 | +71.43% | Beat | N/A | 2 | N/A | Nov 5, 2020 | $7000 |
| Jun 30, 2020 | -$2.80 | -$3.80 | -$4.80 - -$2.80 | +26.32% | Beat | N/A | 2 | N/A | Aug 3, 2020 | N/A |
| Mar 31, 2020 | -$4.40 | -$4.00 | N/A | -10.00% | Miss | N/A | N/A | N/A | May 7, 2020 | $8000 |
| Dec 31, 2019 | -$0.13 | -$0.09 | -$0.14 - -$0.05 | -44.44% | Miss | N/A | 2 | N/A | Feb 20, 2020 | $7000 |
| Sep 30, 2019 | -$7.42 | -$6.40 | -$6.40 - -$2.40 | -15.94% | Miss | N/A | 2 | N/A | Oct 30, 2019 | $8000 |
| Jun 30, 2019 | -$3.60 | -$6.40 | -$6.40 - -$2.00 | +43.75% | Beat | N/A | 2 | N/A | Jul 31, 2019 | $1.83M |
| Mar 31, 2019 | -$0.09 | -$0.24 | N/A | +62.50% | Beat | N/A | N/A | N/A | May 1, 2019 | $921000 |
| Dec 31, 2018 | -$2.00 | -$4.40 | -$4.40 - -$4.40 | +54.55% | Beat | N/A | 1 | N/A | Feb 27, 2019 | $4.52M |
| Sep 30, 2018 | -$2.40 | -$4.80 | -$4.80 - -$4.80 | +50.00% | Beat | N/A | 1 | N/A | Nov 8, 2018 | $3.38M |
| Jun 30, 2018 | -$12.40 | -$16.00 | -$16.00 - -$3.60 | +22.50% | Beat | N/A | 3 | N/A | Aug 3, 2018 | $2.47M |
| Mar 31, 2018 | -$12.00 | -$16.40 | -$16.80 - -$7.20 | +26.83% | Beat | N/A | 4 | N/A | May 15, 2018 | $2.06M |
| Dec 31, 2017 | -$17.60 | -$16.60 | -$18.00 - -$15.60 | -6.02% | Miss | N/A | 3 | N/A | Feb 27, 2018 | $233000 |
| Sep 30, 2017 | -$15.20 | -$15.80 | N/A | +3.80% | Beat | N/A | N/A | N/A | Nov 1, 2017 | $15000 |
| Jun 30, 2017 | -$16.40 | -$18.00 | N/A | +8.89% | Beat | N/A | N/A | N/A | Aug 2, 2017 | $13000 |
| Mar 31, 2017 | -$17.60 | -$17.60 | N/A | 0.00% | In line | N/A | N/A | N/A | May 3, 2017 | $30000 |
| Dec 31, 2016 | -$0.42 | -$0.28 | N/A | -50.00% | Miss | N/A | N/A | N/A | Feb 27, 2017 | $38000 |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$3.35, after -$3.42 the year before. It was -$52.42 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$3.35 | N/A |
| Dec 31, 2024 | -$3.42 | N/A |
| Dec 31, 2023 | -$5.00 | N/A |
| Dec 31, 2022 | -$10.00 | N/A |
| Dec 31, 2021 | -$4.51 | N/A |
| Dec 31, 2020 | -$8.38 | N/A |
| Dec 31, 2019 | -$11.24 | N/A |
| Dec 31, 2018 | -$28.80 | N/A |
| Dec 31, 2017 | -$66.80 | N/A |
| Dec 31, 2016 | -$52.42 | N/A |
Frequently Asked Questions About VTVT
When is vTv Therapeutics's next earnings date?
vTv Therapeutics's next earnings report is expected for Mar 8, 2027.
Did VTVT beat earnings estimates last quarter?
Yes. vTv Therapeutics reported EPS of -$0.94 for the quarter ended Sep 30, 2026, above the -$1.07 estimate, a 12.15% surprise.
What EPS do analysts expect from VTVT next quarter?
The consensus EPS estimate for vTv Therapeutics for the quarter ending Dec 31, 2026 is -$1.29 from 9 analysts, with estimates from -$1.42 to -$1.13.
How often does VTVT beat earnings estimates?
vTv Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +89.15%.
VTVT pages: Overview, Earnings, Forecast, Financials, Competitors